Cerebral infarction (CI) is one of the most common causes of death and disability 1 with a complex etiology involving both genetic and environmental contributions 2, 3 . Recent advances have revealed that inflammation is an essential process in the pathogenesis of CI 4 . Inflammation is influenced by many different cytokines, such as transforming growth factor beta1 (TGFβ1), the most common variant of 3 isoforms (TGFβ1, 2 and 3). The TGFβ1 gene is located on chromosome 19q13. It comprises seven exons and nine introns and produces mRNA of 2.5 kb 5 . There are several commonly known (potentially) functional polymorphisms in this gene. The production of TGFβ1 is predominantly under genetic control and several single nucleotide polymorphisms (SNPs) in human TGFβ1 have been identified. Two functional SNPs, +869T>C (29T>C or Leu10pro, rs1800470) and-509C>T (-1347C>T, rs1800469) have been reported to modify the serum level of TGFβ1 [6] [7] [8] .
AbstRAct:
Background: Transforming growth factor beta1 (TGFβ1) is a multifunctional cytokine involved in inflammation and pathogenesis of atherosclerosis. The aim of the present study was to investigate the relationship between human TGFβ1 gene +869T>C (rs1800470), -509C>T (rs1800469) single nucleotide polymorphisms (SNPs) and haplotypes and cerebral infarction (CI) in a Chinese population. Methods: The genetic association study was performed in 450 Chinese patients (306 male and 144 female) with CI and 450 control subjects (326 male and 124 female). TGFβ1 gene +869T>C and -509C>T polymorphisms were identified with amplification refractory mutation system polymerase chain reaction and DNA sequencing method. Results: The individual SNPs analysis showed the +869T and -509C in an additive model (+869T vs +869C; -509 C vs T), +869TT 
ORIGINAL ARtIcLe
To date, few studies have been published on the association of the TGFβ1 polymorphism and risk of CI [9] [10] [11] . The sparse results available are inconsistent. All of these studies have focused on independent associations with single SNPs, with only one examining TGFβ1 haplotypes 11 . However, haplotype-based association studies have been proposed as a powerful and comprehensive approach for mapping causal genetic variation underlying complex disease, such as CI [12] [13] [14] . Therefore, we conducted this case control study, to investigate the relationship between of SNPs and haplotypes in TGFβ1 gene and CI.
mAteRIALs ANd metHOds study Population
The study protocol included history taking, neurological examination, extracranial and transcranial ultrasound, neuroimaging and laboratory testing. This study was conducted on patients who were consecutively admitted to the Department of Neurology of Jinhua Central Hospital and Jinhua People's Hospital (July, 2007 to December, 2011). A total of 450 consecutive patients presenting with CI were recruited. The diagnosis of CI was defined as ischemic stroke with signs and symptoms lasting >24 hours and having relevant lesions as detected by magnetic resonance imaging (MRI) or computed tomogram (CT). All patients with CI were further categorized into its subtypes using Trial of org10172 in Acute Stroke Treatment (ToAST) classification 15 . Patients with potential sources of cardio-embolism (e.g., atrial fibrillation, recent myocardial infarction, mechanical prosthetic valve, dilated myocardiopathy, and mitral rheumatic stenosis.) were excluded from study. History taking, physical examination, and routine diagnostic tests (electrocardiogram and findings on neuroimaging studies) were sufficient to easily make the diagnosis of most presumed cardiac emboligenic conditions (e.g., atrial fibrillation, recent myocardial infarction, prior rheumatic disease, valve replacement surgery). echocardiography (both transthoracic and/or transoesophageal) was used to reveal structural cardiopathies (dilated cardiomyopathies, mitral stenosis and mechanical prosthetic valve). As a result, 189 patients had large artery atherosclerosis, 201 had small vessel occlusion (Svo), and 60 were diagnosed as stroke with other determined etiology or stroke of undetermined etiology. based on negative history of stroke and negative findings of brain CT or MRI, a total of 450 control subjects without CI were recruited during their routine annual health check-up from the same geographic locations as the patients.. Sampling was stratified to a similar distribution of age, sex and conventional vascular risk factors as the patients in the study. The subjects highly suspected of having a stroke were excluded by performing a CT or MRI scan.
The evaluation of risk factors in both cases and controls included age, sex, body mass index (bMI, kg/m 2 ), hyperlipemia, smoking status, hypertension and diabetes mellitus. Systemic arterial hypertension was defined as a systolic blood pressure of 140 mm Hg, and/or a diastolic blood pressure of 90 mm Hg, at least on two separate occasions, or antihypertensive treatment. Hyperlipemia was defined as either an elevated fasting total cholesterol level above 220mg/dL (5.7mmol/l) or fasting triglyceride level above 150 mg/dl (1.7mmol/l) or current treatment with lipid-lowering medication 16 . Current or former smokers were defined as having used tobacco for one or more years. Diabetes mellitus was defined as the presence of an active treatment with insulin or an oral antidiabetic agent; for patients administered dietary treatment, documentation of abnormal fasting blood glucose or glucose tolerance test based on the World Health organization criteria was required for establishing this diagnosis.
All patients and control subjects were Chinese. They were all unrelated. Written informed consent was obtained from all subjects. The study protocol was approved by the Medical ethics Committee of Jinhua.
sNP selection and Genotyping
based on the allelic frequency data for registered SNPs from NCbI dbSNP (http://www.ncbi.nlm.nih.gov/SNP/) databases, SNPs with minor allele frequency > 5% were chosen for study.
venous blood (5 ml) was collected into tubes containing eDTA (disodium salt, 50 mmol/L), and genomic DNA was isolated with a DNA extraction kit (Roche, Switzerland). Genotyping of the +869T>C and -509C>T polymorphisms of TGFβ1 were performed by the amplification refractory mutation system polymerase chain reaction (ARMS-PCR) method 17, 18 . All reagents for PCR were purchased from Roche Diagnostics (Roche, Switzerland). The primers were synthesized at the SbS Genetech Co (beijing, China). The ARMS-PCR technique uses four primers as follows: a forward outer primer, a reverse outer primer, a forward inner wild type specific primer and a reverse inner mutant specific primer. PCR reaction was performed within a total volume of 25 μL containing 2 μL 10x PCR buffer (Mg2+ Plus), 2 μL 2.5 mM Dntp, 0.5 μL each primer (10 μM), 2 μL genome samples and distilled water. PCR amplification conditions were an initial denaturation at 94℃ for 8 minutes, followed by 20 cycles of melting at 94℃ for 30s, annealing at 58℃ (869 site) and 60℃ (509 site) for 30s, and extension at 72℃ for 40s, with final extension at 72℃ for 5 minutes. The TGFβ1 genotype was determined by 2.0% agarose-gel electrophoresis of PCR products followed by ethidium bromide staining. The 869C allele produced a 248-bp fragment, whereas 869T allele produced a 290-bp fragment. The -509C allele produced a 507-bp fragment, whereas -509T allele produced a 248-bp fragment.
The DNA sequencing was performed on 140 random samples. It confirmed the match between the product sequence and the established TGFβ1 sequence.
statistical Analysis
Power and Sample Size Calculation Software 2.1 was used for sample size calculation. We assumed α=0.05 (two-sided) with power = 80% using a 1:1 ratio of cases to controls while looking for an odds ratio (oR) of 1.5. We assumed the rate of +869TT or -509CC genotype in the source population (controls) is 30%. It indicates that n =425 cases and controls are required in this study.
SPSS equilibrium. Logistic regression models were used for calculating odds ratios (95% confidence interval (CI) and corresponding P values, controlling for age (continuous value), gender (female = 0, male = 1) and the presence of risk factors (negative = 0, positive = 1) as co-variates. TGFβ1 genotype was calculated according to a dominant (+869T>C: CC=0, TC=TT=1; -509C>T: TT=0, CT=CC=1), recessive (+869T>C: TC=CC=0, TT=1; -509C>T: CT=TT=0, CC=1) and additive genetic model (+869T>C: C=0, T =1; -509C>T: T=0, C=1). The oR and 95% CI were also calculated. Statistical significance was taken as P<0.05 (2 tailed). The linkage disequilibrium and haplotype analysis (D' and r 2 ) were performed using the online software SHesis (http://analysis.bio-x.cn/myAnalysis.php). The threshold value of the frequencies of the haplotypes included in the analysis was set to 2%. All haplotypes below the threshold value were excluded from the analysis.
ResuLts
Clinical characteristics of the patients with CI and controls are summarized in Table1. There were no significant differences in age, sex, bMI or conventional risk factors (P>0.05; Table 1 ). We found that the prevalence of hypertension was more frequent among CI patients than control group (P<0.05, Table 1 ).
The genotype distribution and the allele frequency for +869T>C and -509C>T polymorphisms are shown in Table 2 . The genotype distributions among patients and controls were in Hardy-Weinberg equilibrium (+869T>C: X 2 =0.55, P=0.45, df=1; -509C>T: X 2 =0.59, P=0.44, df=1). Analysis demonstrated that there were significant differences in the overall distribution of genotypes and allele of +869T>C and -509C>T between the CI and the control groups. The univariate analysis showed that subjects carrying +869TT genotype were at a 1.56-fold elevated risk for CI (oR= 1.56, 95%CI, 1.17-2.08; P= 0.003) as compared with those carrying TC and CC genotype. A marginally significant increase in risk of CI was found in +869T allele carriers as compared with the +869C allele carriers (oR=1.22, 95%CI, 0.99-1.51; P=0.065). Subjects carrying the -509C allele (CC+CT) were at a 1.61-fold elevated risk for CI (oR=1.61, 95%CI, 1.17-2.26; P= 0.004) as compared those homozygous for the -509TT genotype. The C allele at -509C>T was also [9] Case-control case 271
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Changsha, Hunan identified to be related to CI (oR=1.28, 95%CI, 1.07-1.55; P= 0.008). Further analysis in a multiple logistic regression model revealed that the positive relationships between the +869TT genotype in a recessive model (TT vs TC+CC), -509C allele in additive model (C vs T) and -509CC genotype in a dominant model (CC+ CT vs TT) and CI remained unchanged (P<0.05); However, the marginally significant association between the +869T allele and CI revealed by the univariate analysis changed (adjusted oR=1.27, P=0.035) . Table 3 presents the haplotype frequency distribution of the TGFβ1 and its relationship with CI. Strong linkage disequilibrium (d'=0.87, R 2 =0.75) is detected between two SNPS in TGFβ1 gene. In the haplotype analysis of +869T>C and -509C>T, four haplotypes were identified. In accordance with the principles of haplotype analysis, the +869C/-509C and +869T/-509T haplotypes in control group were excluded in case-control studies because the frequencies are less than 0.02 (http//www.hapmap.org). Haplotype of +869C/-509T was significantly less frequent in the CI group (40.0%) than in the non-CI group (49%) (P<0.05), whereas +869T/-509C haplotype distribution was marginally significant (0.1 > P > 0.05) ( Table 3 ). Multiple regression analysis shows that +869C/-509T haplotype was associated with a significant decreased risk of CI (oR= 0.86, 95%CI, 0.70-0.92; P=0.007). Furthermore, +869T/-509C haplotype was associated with a significant increased risk of CI (oR= 1.31, 95%CI, 1.10-2.03; P= 0.019).
dIscussION
The present study revealed that the -509C>T, +869T>C polymorphisms of the TGFβ1 gene were associated with susceptibility to CI in a Chinese population. The major findings of our study were as follows: (1) +869T allele, +869TT genotype in a recessive model, -509C allele and -509CC genotype in an additive model were identified independently to be related to CI. (2) +869T/-509C haplotype was associated with significantly increased risks of CI. Although the prevalence of hypertension was more frequent among CI patients than control group, we have selected the logistic regression analysis to minimise the confounding bias.
Few studies examined the TGFβ1 gene variant as a risk factor in stroke [8] [9] [10] . The sparse results available are inconsistent. Table  4 shows studies on the association between TGFβ1 gene polymorphism and CI. The positive association between the +869TT genotype and the risk of ischemic stroke (oR=1.63, P=0.026) in a Korean population 9 were in accordance with our results. However,the results in our present study provided more convincing evidence of a causal relationship between TGFβ1 and CI because of controlling confounding variables and large numbers (n=900) of subjects. In the large prospective cohort study with more than 6000 Caucasians individuals, +869C allele and -509T was found to be a risk factor for stroke as a whole but not for ischemic stroke 10 . In contrast, another case-control study from a Chinese population showed that alleles of -509T and +869C and haplotype of -509T/+869C were more frequent in CI patients than in controls 11 . A high degree of linkage disequilibrium was observed between pairs of the +869T>C and -509C>T SNPs in our study, in agreement with previous studies 19, 20 . In this regard, further haplotype analysis of the two polymorphisms was conducted, which is more useful for the identification of predisposing genes of complicated diseases [12] [13] [14] . Results in the present study demonstrated that +869T/ -509C haplotype was associated with a higher risk for developing CI. The risk of CI occurring in subjects carrying this haplotype was 1.31-fold higher (P = 0.019) than in those without the +869T/ -509C haplotype. Conversly, Peng et al found the frequency of the +869C /-509T combined genotype was significantly higher in the CI group than in controls (P < 0.001) 11 . There are several potential explanations for the divergent results. one important aspect is genetic heterogeneity; different TGFβ1 SNPs may be involved in different populations and the pathology of the disease may also differ between the populations. Another important aspect to consider in this context is phenotypic heterogeneity. The etiology of CI is heterogeneous and genetic factors may vary by etiologic subtype. unlike our present study, cardioembolic CI patients have not been excluded in the analysis in most of the previous studies 9, 10 .
It has been well documented that TGFβ1 is a pleiotropic cytokine with potent anti-inflammation properties 21 . Therefore, it is conceivable that subjects carrying +869T or -509C alleles might be at greater risk for CI, because such alleles are associated with decreased TGFβ1 level 6, 8, 22 .
The potential limitations of our study warrant consideration. Firstly, we may not have captured all common genetic variations in TGFβ1 in this study and we genotyped variants that are likely to have a functional impact on the expression or activation of TGFβ1, and thus, which may be more important for CI risk. Secondly, as all study subjects are Chinese, our results may not be generalized to other ethnic populations with different environmental exposures. Additional studies are needed to confirm these findings. Finally, it is not possible to completely exclude potential statistical errors such as false-positives.
cONcLusION
In conclusion, we found that the -509C>T and +869T>C polymorphisms of the TGFβ1 gene were associated with susceptibility to CI in a Chinese population. This study gives additional support to the important role of inflammation in the pathogenesis of CI.
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